Joint Formulary & PAD

Formoterol (Oxis Turbohaler) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Formoterol (Oxis Turbohaler)
Indication :
Asthma
Group Name :
LABA
Keywords :
LABA, respiratory, asthmatics, Selective beta2-agonists, long-acting beta agonists
Brand Names Include :
Pulmicort Turbohaler
Important Information :

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Formoterol (Oxis Turbohaler) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.